Posted 16 July, 2021
SERA PROGNOSTICS, INC. IPO completed
IPO completed detected for ticker Nasdaq:SERA in a 424B4 filed on 16 July, 2021.
This is an initial public offering of shares of Class A common stock of Sera Prognostics, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of SERA PROGNOSTICS, INC.
Health Care/Life Sciences • Biotechnology
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.Market Cap
$287M
View Company Details
$287M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.